4月24日 - ** Caribou Biosciences CRBU.O股票在延时交易中上涨3%至89美分
** 该公司表示，它将把 (link)，减少32%的员工，以将其现金流延长至2027年下半年；截至3月31日，该公司拥有约2.125亿美元现金
** 截至 3 月 1 日，CRBU 共有 147 名全职员工 (link) - SEC 文件
** 公司表示将优先考虑两个癌症治疗项目：CB-010 和 CB-011
** 还表示将停止狼疮和白血病治疗试验的工作
** 截至上一交易日收盘，股价累计下跌 45
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.